Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;51(6):1829-1835.
doi: 10.1002/jmri.26984. Epub 2019 Nov 11.

Multiparametric Quantitative Brain MRI in Neurological and Hepatic Forms of Wilson's Disease

Monika Dezortova  1 , Artem Lescinskij  1   2 , Petr Dusek  2   3 , Vit Herynek  1   4 , Julio Acosta-Cabronero  5 , Radan Bruha  6 , Filip Jiru  1 , Simon D Robinson  7 , Milan Hajek  1
Affiliations

Multiparametric Quantitative Brain MRI in Neurological and Hepatic Forms of Wilson's Disease

Monika Dezortova et al. J Magn Reson Imaging. 2020 Jun.

Abstract

Background: In Wilson's disease (WD), demyelination, rarefaction, gliosis, and iron accumulation in the deep gray matter cause opposing effects on T2 -weighted MR signal. However, the degree and interplay of these changes in chronically treated WD patients has not been quantitatively studied.

Purpose: To compare differences in brain multiparametric mapping between controls and chronically treated WD patients with neurological (neuro-WD) and hepatic (hep-WD) forms to infer the nature of residual WD neuropathology.

Study type: Cross-sectional.

Population/subjects: Thirty-eight WD patients (28 neuro-WD, 10 hep-WD); 26 healthy controls.

Field strength/sequence: 3.0T: susceptibility, T2 *, T2 , T1 relaxometry; 1.5T: T2 , T1 relaxometry.

Assessment: The following 3D regions of interest (ROIs) were manually segmented: globus pallidus, putamen, caudate nucleus, and thalamus. Mean bulk magnetic susceptibility, T2 *, T2 , and T1 relaxation times were calculated for each ROI.

Statistical tests: The effect of group (neuro-WD, hep-WD, controls) and age was assessed using a generalized least squares model with different variance for each ROI and quantitative parameter. A general linear hypothesis test with Tukey adjustment was used for post-hoc between-group analysis; P < 0.05 was considered significant.

Results: Susceptibility values were higher in all ROIs in neuro-WD compared to controls and hep-WD (P < 0.001). In basal ganglia, lower T2 and T2 * were found in neuro-WD compared to controls (P < 0.01) and hep-WD (P < 0.05) at 3.0T. Much smaller intergroup differences for T2 in basal ganglia were observed at 1.5T compared to 3.0T. In the thalamus, increased susceptibility in neuro-WD was accompanied by increased T1 at both field strengths (P < 0.001 to both groups), and an increased T2 at 1.5T only (P < 0.001 to both groups).

Data conclusion: We observed significant residual brain MRI abnormalities in neuro-WD but not in hep-WD patients on chronic anticopper treatment. Patterns of changes were suggestive of iron accumulation in the basal ganglia and demyelination in the thalamus; 3.0T was more sensitive for detection of the former and 1.5T of the latter abnormality.

Level of evidence: 2 Technical Efficacy Stage: 3 J. Magn. Reson. Imaging 2020;51:1829-1835.

Keywords: Wilson's disease; brain; magnetic resonance imaging; quantitative susceptibility mapping; relaxation time.

PubMed Disclaimer

References

    1. Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers 2018;4:21.
    1. Litwin T, Gromadzka G, Czlonkowska A, Golebiowski M, Poniatowska R. The effect of gender on brain MRI pathology in Wilson's disease. Metab Brain Dis 2013;28:69-75.
    1. Zhong W, Huang Z, Tang X. A study of brain MRI characteristics and clinical features in 76 cases of Wilson's disease. J Clin Neurosci 2019;59:167-174.
    1. Kozic DB, Petrovic I, Svetel M, Pekmezovic T, Ragaji A, Kostic VS. Reversible lesions in the brain parenchyma in Wilson's disease confirmed by magnetic resonance imaging: Earlier administration of chelating therapy can reduce the damage to the brain. Neural Regen Res 2014;9:1912-1916.
    1. Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK. Sequential MRI changes in Wilson's disease with de-coppering therapy: A study of 50 patients. Br J Radiol 2007;80:744-749.

Publication types